跳到主要内容
  • Sign in
    Welcome !
    My account
    Logout

Nautilus Biotechnology, Inc. (NAUT) Stock Forecast 2025 - AI Price Prediction & Analysis

Nautilus Biotechnology, Inc. (NAUT) AI Stock Price Forecast & Investment Analysis

Nautilus Biotechnology, Inc. Stock Price Chart and Technical Analysis

Loading Nautilus Biotechnology, Inc. interactive price chart and technical analysis...

Nautilus Biotechnology, Inc. (NAUT) - Comprehensive Stock Analysis & Investment Research

Company Overview & Business Profile

Nautilus Biotechnology, Inc. (Stock Symbol: NAUT) is a leading company in the Industrial Applications and Services sector , specifically operating within the Laboratory Analytical Instruments industry. The organization employs approximately 170 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.

Financial Performance & Key Metrics Analysis

Annual Revenue: $707 million generating a 3.1% net profit margin .

Market Capitalization: $86 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -16.5% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Advanced AI Stock Prediction & Price Target Analysis

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Nautilus Biotechnology, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Market Position & Competitive Advantage Analysis

Nautilus Biotechnology, Inc. strategically competes in the highly dynamic Laboratory Analytical Instruments marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company maintains a healthy 42.3% gross margin, indicating strong pricing power and operational efficiency.

Nautilus Biotechnology, Inc. (NAUT) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Nautilus Biotechnology, Inc. stock analysis.

Loading Nautilus Biotechnology, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Nautilus Biotechnology, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Nautilus Biotechnology, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Nautilus Biotechnology, Inc.: With a P/E ratio of -3.78, the market sees the stock as potentially undervalued.

P/E Ratio -3.78x
P/B Ratio 0.47x
Market Cap $86M
EPS $-0.52
Book Value/Share $1.43
Revenue/Share $20.79
FCF/Share $1.06
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Nautilus Biotechnology, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Nautilus Biotechnology, Inc.: An ROE of -16.5% indicates room for improvement in shareholder value creation.

ROE -16.5%
ROA -15.0%
ROIC -15.2%
Gross Margin 42.3%
Operating Margin 7.5%
Net Margin 3.1%
EBT Margin 4.9%
Tax Rate 37.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Nautilus Biotechnology, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Nautilus Biotechnology, Inc.: A current ratio of 51.05 indicates strong liquidity.

Current Ratio 51.05x
Quick Ratio 50.60x
D/E Ratio 0.08x
Financial Leverage 1.10x
Working Capital $191M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Nautilus Biotechnology, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Nautilus Biotechnology, Inc.: Free cash flow of $-48M indicates cash challenges that need attention.

Operating Cash Flow $-45M
Free Cash Flow $-48M
Capital Spending $-2M
FCF/Sales 3.3%
CapEx/Sales 3.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Nautilus Biotechnology, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Nautilus Biotechnology, Inc.: An asset turnover of 1.59x demonstrates efficient asset utilization.

Asset Turnover 1.59x
Receivables Turnover 10.2x
Inventory Turnover 5.1x
Fixed Assets Turnover 7.0x
Days Sales Outstanding 36 days
Days Inventory 71 days
Payables Period 34 days
Cash Conversion Cycle 73 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Nautilus Biotechnology, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Nautilus Biotechnology, Inc.: With annual revenue of $707M, Nautilus Biotechnology, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $707M
Operating Income $-2M
R&D Expense $50M
SG&A Expense $36M
Cost of Goods Sold $58M
Balance Sheet Highlights ($ Millions)
Total Current Assets $85M
Cash & Short-term Investments $84M
Total Liabilities $9M
Short-term Debt $0M
Accounts Receivable $16M
Inventory $20M
Dividend & Shareholder Information
Shares Outstanding 126M
Growth Metrics (YoY)
EPS Growth -20.2%

Latest Nautilus Biotechnology, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Nautilus Biotechnology, Inc. (NAUT) stock price and investment outlook.

📰 We are currently updating our news feed for Nautilus Biotechnology, Inc.. Check back soon for the latest market analysis and company updates.

Nautilus Biotechnology, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Nautilus Biotechnology, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
A Unlock Forecast $35685M 29.3x 5.6x
AKYA Unlock Forecast $64M -2.1x -10.9x
ASTC Unlock Forecast $9M 28.9x 0.4x
AVTR Unlock Forecast $9064M 13.2x 1.4x
AXDX Unlock Forecast $0M -0.2x 0.0x
BIO Unlock Forecast $8020M 25.1x 1.1x
BIO-B Unlock Forecast $6816M 21.4x 1.0x
BNGO Unlock Forecast $15M 0.0x 0.3x
BRKR Unlock Forecast $6145M 28.3x 3.2x
CTKB Unlock Forecast $528M 82.0x 1.4x
EYPT Unlock Forecast $808M -4.4x 3.3x
HBIO Unlock Forecast $22M -8.3x 1.4x
ILMN Unlock Forecast $15456M 12.3x 6.8x
LAB Unlock Forecast $481M -2.4x 1.1x
LCTC Unlock Forecast $9M x 1.5x
MTD Unlock Forecast $24913M 31.5x -136.9x
NAUT Unlock Forecast $86M -3.8x 0.5x
OMIC Unlock Forecast $50M -1.7x 0.4x
PACB Unlock Forecast $393M -1.5x 6.4x
PRPO Unlock Forecast $22M -1.2x 0.6x
QTRX Unlock Forecast $209M -11.1x 0.7x
RPID Unlock Forecast $107M -0.9x 2.0x
RVTY Unlock Forecast $10446M 36.6x 1.4x
SEER Unlock Forecast $130M -2.0x 0.4x
TXG Unlock Forecast $1659M -8.6x 2.2x
WAT Unlock Forecast $17696M 26.8x 8.2x

Frequently Asked Questions - Nautilus Biotechnology, Inc. Stock Forecast

How accurate are Nautilus Biotechnology, Inc. stock predictions?

Our AI model demonstrates 56% historical accuracy for NAUT predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Nautilus Biotechnology, Inc. stock price forecasts?

Our analysis considers Nautilus Biotechnology, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Nautilus Biotechnology, Inc. a good investment in 2025?

Based on our AI analysis, Nautilus Biotechnology, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Nautilus Biotechnology, Inc. forecasts updated?

Nautilus Biotechnology, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Nautilus Biotechnology, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Nautilus Biotechnology, Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...